The EU backed Innovative Medicines Initiative has updated its strategic research agenda, outlining strategies to overcome 'bottlenecks' to efficient R&D for new medicines.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.